# taVNS Effect on Central Auditory Processing

> **NCT06970444** · NA · COMPLETED · sponsor: **Medipol University** · enrollment: 70 (actual)

## Conditions studied

- Central Auditory Disease
- Auditory Processing Disorder, Central
- Auditory Processing Disorders
- Vagus Nerve Stimulation

## Interventions

- **DEVICE:** transcutaneous auricular vagus nerve stimulation (taVNS)
- **OTHER:** Sham device

## Key facts

- **NCT ID:** NCT06970444
- **Lead sponsor:** Medipol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-07-19
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06970444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06970444, "taVNS Effect on Central Auditory Processing". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06970444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*